Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded Valparaiso and Araucania locations, including Temuco, Araucania, Chile (4810469) and Viña del Mar, Valparaiso, Chile (2540364). Removed Temuco, Región de la Araucanía, Chile (4810469) and Viña del Mar, Región de Valparaíso, Chile (2540364); revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and the previous v3.4.2 revision was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor site version update that does not affect study content or user actions; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision metadata updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.